Enhanced hit-to-lead process using bioanalogous lead evolution and chemogenomics: application in designing selective matrix metalloprotease inhibitors Article

Papp, Akos, Szommer, Tamas, Barna, Laszlo et al. (2007). Enhanced hit-to-lead process using bioanalogous lead evolution and chemogenomics: application in designing selective matrix metalloprotease inhibitors . 2(5), 707-723. 10.1517/17460441.2.5.707

Industry Collaboration

cited authors

  • Papp, Akos; Szommer, Tamas; Barna, Laszlo; Gyimesi, Gergely; Ferdinandy, Peter; Spadoni, Cesare; Darvas, Ferenc; Fujita, Toshio; Uerge, Laszlo; Dorman, Gyoergy

sustainable development goals

authors

publication date

  • May 1, 2007

keywords

  • BINDING-SITES
  • CHEMOMETRICAL APPROACH
  • DRUG DISCOVERY
  • EMIL
  • GENERATION
  • LIGANDS
  • Life Sciences & Biomedicine
  • MMP
  • NATURAL-PRODUCT STRUCTURE
  • PRIVILEGED STRUCTURES
  • Pharmacology & Pharmacy
  • SIMILARITY
  • SPACE
  • Science & Technology
  • TARGET FAMILY LANDSCAPE
  • bioanalogous design
  • chemogenomics
  • evolution tree
  • matrix metalloproteases
  • matrixinome
  • matrixins
  • medicinal chemistry
  • selectivity jumping

Digital Object Identifier (DOI)

publisher

  • TAYLOR & FRANCIS LTD

start page

  • 707

end page

  • 723

volume

  • 2

issue

  • 5